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Severe congenital neutropenia (SCN) is character-
ized by a deficiency of mature neutrophils, leading
to recurrent bacterial and fungal infections. Although
mutations in Elastase-2, neutrophil (ELA2) predomi-
nate in human SCN, mutation of Ela2 in mice does
not recapitulate SCN. The growth factor indepen-
dent-1 (GFI1) transcription factor regulates ELA2.
Mutations in GFI1 are associated with human SCN,
and genetic deletion of Gfi1 results in murine neutro-
penia. We examined whether human SCN-associ-
ated GFI1N382S mutant proteins are causal in SCN
and found that GFI1 functions as a rate-limiting gran-
ulopoietic molecular switch. The N382S mutation in-
hibitedGFI1 DNAbinding and resulted in a dominant-
negative block to murine granulopoiesis. Moreover,
Gfi1N382S selectively derepressed the monopoietic
cytokine CSF1 and its receptor. Gfi1N382S-express-
ing Csf1/ cells formed neutrophils. These results
reveal a common transcriptional program that under-
lies both human andmurine myelopoiesis, and that is
central to the pathogenesis of SCN associated with
mutations in GFI1. This shared transcriptional path-
way may provide new avenues for understanding
SCN caused bymutations in other genes and for clin-
ical intervention into human neutropenias.
INTRODUCTION
Severe congenital neutropenia (SCN) is characterized by matura-
tion arrest at the promyelocyte stage in the bone marrow. SCN
patients demonstrate deficient numbers of mature neutrophils
and are subsequently prone to recurrent bacterial and fungal in-
fections (Horwitz et al., 2007). Current treatment with recombi-
nant granulocyte-colony stimulating factor (G-CSF) increases
the rate of granulopoiesis for most—but not all—patients yet fails370 Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc.to correct an underlying defect in the expression of granule pro-
teins (Donini et al., 2007), resulting in increased numbers of, albeit
somewhat functionally defective, neutrophils in the peripheral
circulation. SCN patients also frequently develop myelodysplasia
or acute myelogenous leukemia (Rosenberg et al., 2006), and
there is concern that G-CSF therapy might accelerate leukemo-
genesis. Autosomal-dominant mutation of Elastase 2, neutrophil
(ELA2) is the most common cause of SCN (Horwitz et al., 2007),
but autosomal-dominant mutation of the gene involved in Wis-
kott-Aldrich syndrome (WAS) (Ancliff et al., 2006) and Growth
factor independent-1 (GFI1) (Person et al., 2003) and, recently, re-
cessive mutations inHCLS1-associated protein X-1 (HAX1) (Klein
et al., 2007) have also been described. Unfortunately, modeling
SCN in mice is difficult because neither the targeting of SCN-
associated mutations into murine Ela2 (Grenda et al., 2002) nor
complete deletion of Ela2 (Belaaouaj et al., 1998) has an effect
on murine hematopoiesis.
Gfi1 is a zinc-finger transcription factor with a SNAG (Snail +
Gfi1) amino-terminal transcriptional-repressor domain (Grimes
et al., 1996a; Zweidler-Mckay et al., 1996). Gfi1 is normally
expressed in hematopoietic stem cells (HSCs) and progenitors
and controls cell growth and differentiation (Hock et al., 2003;
Karsunky et al., 2002b; Zeng et al., 2004). We previously de-
scribed a family of SCN patients with GFI1N382S mutations
and hypothesized that GFI1N382S functions as a dominant-neg-
ative-acting protein (Person et al., 2003). Similar to GFI1N382S
humans, Gfi1/ mice lack mature neutrophils (Hock et al.,
2003; Karsunky et al., 2002b). Thus, we reasoned that Gfi1 might
offer a unique opportunity to validate a human SCN-associated
mutant protein as causal in SCN and to determine the molecular
cause of GFI1N382S-induced human disease. Here, we show
that wild-type Gfi1 functions as a rate-limiting molecular switch
to induce granulopoiesis. In contrast, the expression of
Gfi1N382S blocks granulopoiesis in primary murine lineage neg-
ative (Lin) bone-marrow cells through the selective derepres-
sion of Gfi1 target genes. A computational model of the Gfi1
zinc fingers involved in DNA binding and biological validation
of the model allowed us to predict new Gfi1 amino acid substitu-
tions capable of inducing Gfi1N382S-like phenotypes. Notably,
these results demonstrate the limitation of the Gfi1/ mouse
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Murine Severe Congenital NeutropeniaFigure 1. Wild-type Gfi1 Induces, whereas
N382S Mutant Blocks, Granulopoiesis
In Vitro
(A) Transient transcription assay with reporters,
empty MSCV control (V), and MSCV vectors en-
coding Gfi1 (WT) and Gfi1N382S transfected into
293 cells. Results ± SD from three independent ex-
periments depicted as transcriptional repression
(Gfi1-responsive reporter versus control reporter)
are shown. The inset shows immunoblot analysis
with a Gfi1-peptide-specific rabbit polyclonal anti-
sera for detecting expression of MSCV vector-en-
coded proteins in transfected 293 cells.
(B) Methylcellulose colony formation of Lin bone-
marrow cells transduced with MSCV empty vector
(V) or MSCV expressing either Gfi1 WT or
Gfi1N382S. Results of CFU assays are displayed
as the percentage of CFU-G-, -M, and -GM from
three independent wells ± SD with total number
of colonies ± SD.
(C) Cytospin from 4 day G-CSF-stimulated liquid
cultures of Lin bone-marrow cells transduced
with MSCV empty vector (V) or MSCV expressing
either Gfi1 WT or Gfi1N382S. Human GFI1N382S
patient sample cultured with human recombinant
G-CSF from (Person et al., 2003).
(D) Flow-cytometric analysis of liquid cultures in
(C) with 7/4 and F4/80 for denoting neutrophil,
mixed, and monocytic phenotypes.
(E) Methylcellulose colony formation of Lin bone-
marrow cells from wild-type and Gfi1+/ litter-
mates.
(F) Methylcellulose colony formation of Lin
Gfi1/ bone-marrow cells transduced with
MSCV empty vector (V) or MSCV expressing either
Gfi1 WT or Gfi1N382S.Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc. 371as a potential human SCN model and show that Gfi1N382S
selectively functions through the critical deregulation of monop-
oietic inducers Csf1 and Csf1r.
RESULTS
Murine Gfi1N382S Mutant Blocks
Granulopoiesis In Vitro
First, the Gfi1N382S mutation was introduced into a murine Gfi1
cDNA, and its ability to repress transcription was tested. A Gfi1-
responsive reporter construct (Zweidler-Mckay et al., 1996) was
transfected into HEK293 cells along with Gfi1 expression con-
structs. Both wild-type and Gfi1N382S proteins accumulated
similarly in transfected cells (Figure 1A, inset). Similar to our re-
sults with human Gfi1N382S (Person et al., 2003), whereas
wild-type Gfi1 strongly repressed the reporter, Gfi1N382S was
unable to repress the reporter (Figure 1A), Thus, mutation of
N382 in both human and murine Gfi1 cDNAs inhibits transcrip-
tional repression on this reporter construct.
To test the effect of murine Gfi1N382S on granulopoiesis, we
transduced murine bone-marrow lineage negative (Lin) cells
with MSCV-puro retroviral vectors (Hawley, 1994) expressing
either wild-type Gfi1 or the Gfi1N382S mutant. Transduced cells
were assayed for colony formation in methylcellulose with inter-
leukin-3 (IL3), interleukin-6 (IL6), stem cell factor (SCF), and puro-
mycin selection. In comparison to cells transduced with the
empty retrovirus vector, overexpression of wild-type or mutantGfi1 sometimes decreased total colony formation; however,
this was variable and did not reach statistical significance.
Wild-type Gfi1 expressing cells almost exclusively formed gran-
ulocytic colonies (Figure 1B). In striking contrast, cells overex-
pressing Gfi1N382S gave rise to mostly monocytic colonies
(Figure 1B). The assay was repeated with sorted common mye-
loid progenitors (CMPs) and granulocyte monoctye progenitors
(GMPs) with basically the same result (Figure S1 available online).
To eliminate potential variables introduced by our transduction
and selection scheme, we repeated the assay with the CMMP-
iresGFP Moloney-based vector (Klein et al., 2000). Murine
Lin cells were transduced with CMMP-iresGFP vectors encod-
ing the wild-type Gfi1 or the Gfi1N382S mutant and expanded for
36 hr; then, GFP+ cells were sorted. Equal numbers of GFP+ cells
were assayed for colony formation, and the results were essen-
tially the same as those for MSCV-puro vector transduced cells
selected in puromycin (data not shown). Thus, it is unlikely that
differences in colony formation or number are due to unique
properties of the MSCV vector or individual viral stocks. We con-
clude that Gfi1 appears to induce, whereas Gfi1N382S inhibits,
granulocytic-colony formation.
The forced expression of Gfi1 or the Gfi1N382S mutant dra-
matically alters colony formation. However, it is also possible
that the combination of IL3, IL6, and SCF are insufficient to facil-
itate granulocytic differentiation of Gfi1N382S-expressing cells.
To distinguish between these possibilities, we assembled liquid
cultures with an instructive cytokine signal (G-CSF) and analyzed
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row Lin cells overexpressing wild-type Gfi1 or Gfi1N382S
were plated in liquid cultures and stimulated with G-CSF for 4
days. As shown in Figure 1C, vector-transduced cells differenti-
ated mainly to the stage of myelocytes, metamyelocytes, and
a few band neutrophils. In contrast, wild-type Gfi1 overexpress-
ing cells mostly displayed morphological features of band neu-
trophils, whereas Gfi1N382S-expressing cells were blocked in
differentiation at an unknown stage. Interestingly, these G-CSF-
stimulated murine cells overexpressing a murine Gfi1N382S
were morphologically similar to human GFI1N382S mutant pa-
tient stem cells similarly cultured (compare lower- right and left
panels, Figure 1C). In sum, G-CSF signaling was insufficient to
override Gfi1N382S-blocked granulopoiesis.
Gfi1 Resolves the Cell Fate of Early Myeloid Precursors
Flow-cytometric analysis of cells from G-CSF-stimulated liquid
cultures stained with neutrophilic (7/4) (Hirsch and Gordon,
1983) and monocytic (F4/80) (Hume and Gordon, 1983) markers
delineates granulocytes, monocytes, and cells with a mixed my-
eloid phenotype (Figure 1D), which we confirmed with sorted and
stained cytospins (data not shown). In comparison to vector-
transduced cells, cells overexpressing wild-type Gfi1 demon-
strated a shift toward a granulocytic phenotype (compare vector
78% to Gfi1 WT 85%) and a dramatic reduction in undifferenti-
ated cells (compare vector 12% to Gfi1 WT 1%) (Figure 1D). Sur-
prisingly, with these markers, Gfi1N382S-overexpressing cells
showed phenotypic granulocytes (Figure 1D), even though
such cells did not have the cellular morphology of neutrophils
(Figure 1C). However, the number of such phenotypic granulo-
cytes was reduced (compare vector 78% to N382S 56%),
whereas the number of mixed-lineage phenotype cells consider-
ably increased (compare vector 12% to N382S 30%) (Figure 1D).
Taken together, these assays suggest that overexpression of
wild-type Gfi1 induces granulopoiesis and resolves a mixed lin-
eage fate, whereas overexpression of the Gfi1N382S mutant
blocks granulopoiesis at an intermediate stage and/or induces
a phenotype in which differentiation-associated surface markers
and nuclear morphology are disconnected.
Granulopoiesis Is Gfi1-Dose Dependent
Retroviral-vector-mediated forced expression of Gfi1 induced
more granulocytes ex vivo than vector-control-transduced cells
(Figures 1B–1D). To determine whether manipulation of endoge-
nous Gfi1 gene dosage also affects cell differentiation, we com-
pared Gfi1+/+ and Gfi1+/ littermate Lin marrow stem and pro-
genitors in colony-formation assays. Strikingly, the number of
granulocytic colonies generated by Gfi1+/ cells was signifi-
cantly less than that from Gfi1+/+ cells (p < 0.01) (Figure 1E).
Thus, Gfi1 is rate limiting for granulopoiesis.
Gfi1-Induced Granulopoiesis Requires
Sequence-Specific DNA Binding
Germline deletion of Gfi1 blocks the formation of mature neutro-
phils (Hock et al., 2003; Karsunky et al., 2002b).Gfi1/ Lin cells
formed mainly monocytic colonies in vitro (Figure 1F). We trans-
duced Gfi1/ Lin cells with wild-type Gfi1-expressing retrovi-
ruses and analyzed them for colony formation. As previously re-
ported for sorted granulocyte-monoctye progenitors (Hock et al.,372 Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc.2003), forced expression of Gfi1 in Gfi1/ Lin cells restores
granulopoiesis (Figure 1F). Interestingly, forced Gfi1 expression
in Gfi1/ cells did not occlude monopoiesis as it did in Gfi1+/+
cells (Figure 1B). It is formally possible that not all Gfi1/ Lin
cells are capable of responding to Gfi1. However, given the
dose-dependent granulopoiesis demonstrated for Gfi1+/ cells,
it is likely that MSCV retroviral-vector-mediated expression of
Gfi1 is consistent with a dose-dependent effect.
The Gfi1N382S mutant fails to bind a consensus Gfi1 DNA-
binding site (see Figure 3B) (Person et al., 2003). We hypothesize
that Gfi1N382S acts as a dominant negative by sequestering lim-
iting cofactors that are required for wild-type Gfi1 to function
when bound to DNA. However, it is alternatively possible that
the Gfi1N382S mutant is a gain-of-function mutant related to
physical interaction between Gfi1 and the Protein inhibitor of
activated STAT 3 (Pias3) SUMO-E3 ligase or the U2AF26 splic-
ing-factor proteins (Heyd et al., 2006; Rodel et al., 2000). To de-
termine whether Gfi1N382S retains any wild-type Gfi1 activities
relevant to myelopoiesis, we assayed Gfi1N382S activity in the
absence of endogenous Gfi1. In contrast to forced expression
of Gfi1, colony formation of Gfi1N382S-expressing cells was
virtually indistinguishable from that of vector-transduced cells
(Figure 1F), in that Gfi1N382S was similarly unable to rescue
Gfi1/ granulopoiesis. Importantly, the ability of Gfi1 to modu-
late granulopoiesis appears to be critically dependent upon
sequence-specific DNA binding.
A Computational Model of DNA-Bound Gfi1
Zinc Fingers 3, 4, and 5
The Gfi1N382S mutation in zinc finger 5 ablates sequence-spe-
cific DNA binding and has been identified in three related pa-
tients with SCN (Person et al., 2003). Zinc fingers 3, 4, and 5
are absolutely required for sequence-specific DNA binding
(Zweidler-Mckay et al., 1996); however, other than N382S, neu-
tropenic individuals with mutations in these zinc fingers have not
been identified. We were interested in determining whether sin-
gle amino acids (other than N382) in zinc fingers 3, 4, and 5 are
critically required for DNA binding and their subsequent func-
tional role in regulating granulopoiesis. To this end, we utilized
the established crystal structure of a synthetic Cys-His zinc fin-
ger protein (1Mey) (Kim and Berg, 1996) and the Modeler, Clus-
talW, and molecular dynamics (Amber) computer programs to
generate an optimized computational homology model of zinc
fingers 3, 4, and 5 bound to a synthetic ‘‘R21’’ high-affinity Gfi1
binding site (Figure 2A). From the crystal structure of Cys-His
zinc fingers, it is evident that amino acids at 1, 2, 3, and 6 along
the alpha helix of the zinc-finger structure were frequently found
to interact with DNA (Wolfe et al., 2001) (Figure 2B, amino acids
depicted in bold). Indeed, the homology model predicted inter-
action between DNA and amino acids in the alpha helix at these
positions, in addition to others (Figure 2B). The homology model
predicts that amino acids in zinc finger 3 interact with bases out-
side the Gfi1-consensus core binding motif ‘‘AATC,’’ whereas
those in zinc fingers 4 and 5 interact with both the AATC core
and nucleotides in close proximity (Figure 2B, arrows). Interest-
ingly, N382 in zinc finger 5 specifically interacted with two neigh-
boring alanines in and outside the binding core (Figure 2C); how-
ever, when DNA docking of the SCN-associated Gfi1N382S
mutant was forced in the model, only a nonspecific interaction
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(A) Computational model of Gfi1 zinc fingers 3 (contact residues in red), 4 (con-
tact residues in blue), and 5 (contact residues in orange) interacting with the
‘‘R21’’ synthetic high-affinity DNA-binding site (violet).
(B) Graphic representation of interactions between amino acids and nucleo-
tides predicted by the model in (A). The line over DNA sequence indicates
the AATC core of the Gfi1 binding site. Predicted contact nucleotides are
shown in blue. Zinc finger amino acids that normally interact with DNA are in
bold.
(C) Interaction of Gfi1N382 with DNA. Numbers indicate distances in
angstroms.
(D) Interaction of Gfi1N382S with DNA. Numbers indicate distances in
angstroms.with the backbone was predicted (Figure 2D). Thus, the homol-
ogy model predicts how the N382S mutation affects DNA
binding.
Single Amino Acids in Gfi1 Zinc Fingers
4 and 5 Are Critical for DNA Binding
It is possible that N382 interactions with DNA are more important
than other amino acids for sequence-specific DNA binding. To
investigate this possibility and to validate the virtual model, we
first biochemically tested the importance of predicted DNA bind-
ing amino acids (Figure 3A, bold). First, each amino acid pre-
dicted to interact with DNA was mutated to alanine, and then
the mutated Gfi1 cDNAs were in vitro transcribed and translated
(Figure 3B, bottom panel, ‘‘IVT’’). The resulting proteins were
analyzed by electrophoretic mobility-shift assay (EMSA) with ra-
diolabeled oligonucleotides encoding a concensus Gfi1 binding
site (‘‘R21’’). Proteins with zinc finger 3 mutations, zinc finger 4
Gfi1K356A, and zinc finger 5 Gfi1S381A reproducibly demon-
strated slightly reduced binding compared to wild-type Gfi1 (Fig-
ure 3B). On the other hand, both zinc finger 4 Gfi1D354A and
Gfi1K357A mutants and zinc finger 5 Gfi1Q379A and Gfi1S380A
mutants reproducibly demonstrated severely reduced binding
(Figure 3B, middle panel). As expected, the Gfi1N382A and
Gfi1N382S mutants failed to bind DNA. We conclude that Gfi1
amino acids D354, K357, Q379, S380, and N382 are critically re-
quired for sequence-specific DNA binding to the R21 consensus
oligonucleotide.
We next determined whether N382 is uniquely required for
granulopoiesis. The alanine-substitution mutants were retrovir-
ally expressed in Lin bone-marrow cells and subjected to col-
ony assay in methylcellulose, G-CSF-stimulated liquid culture,
and flow-cytometric analysis. As before, expression of wild-
type Gfi1 excluded monocytic-colony development (Figure 3C).
The zinc finger 3 mutants that demonstrated consistent but mod-
est reduction in DNA binding capacity in EMSA (Figure 3B) were
equivalently impaired in occluding monocytic colonies com-
pared to wild-type Gfi1 (Figure 3C). Independent of measurable
DNA binding to the R21 oligonucleotide, expression of zinc finger
4 and 5 mutants dramatically lowered CFU-G formation (Fig-
ure 3C). However, in G-CSF-stimulated liquid cultures, zinc
finger 4 and 5 mutants that lack DNA binding directly correlated
with defective neutrophilic differentiation. Specifically, G-CSF-
stimulated cells expressing Gfi1D354A, Gfi1K357A, Gfi1Q379A,
Gfi1S380A, and Gfi1N382A showed a dramatic decrease in
band neutrophils (Figure 3D, cytospins). Gfi1N382S-expressing
cells display more 7/4hi F4/80hi mixed neutrophilic-monocytic
characteristics (Figure 1D). Similarly, Gfi1Q379A-expressing
cells display an increase in this 7/4hi F4/80hi mixed population
(Figure 3D). Thus, whereas Gfi1 D354A, K357A, Q379A, and
S380A mutations substantially interfered with DNA binding to
the R21 oligonucleotide (Figure 3B) and altered CFU-G forma-
tion, mutation of N382 seems to play a unique role in Gfi1 DNA
binding and control of myelopoiesis, with the Gfi1Q379A mutant
most similarly to N382A. Interestingly, N382 and Q379 specify
neighboring core nucleotides in the Gfi1 DNA binding site (Fig-
ure 2B). Clearly, both Gfi1N382A- and Gfi1N382S-expressing
cells display the most dramatic expansion of an atypical mixed
7/4hi F4/80hi population combined with a profound lack of
band neutrophils in G-CSF-stimulated cultures.Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc. 373
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Murine Severe Congenital NeutropeniaFigure 3. Gfi1 DNA Binding Is Required for
G-CSF Induced Granulopoiesis
(A) Amino acid sequence depicting Gfi1 zinc finger
3, 4, and 5. Amino acids predicted (by the compu-
tational model in Figure 2) to interact with DNA are
in bold and large font.
(B) Alanine-substitution mutants or a luciferase
control (Luc.) were in vitro transcribed and
translated (IVT, bottom), then incubated with a ra-
diolabeled ‘‘R21’’ oligonucleotide. EMSA (middle
panel) revealed shifted oligonucleotides (arrow).
Panels are derived from an autoradiogram of a
single gel that has been divided for clarity of
presentation.
(C) Methylcellulose colony formation of Lin bone-
marrow cells transduced with MSCV empty vector
(V) or MSCV expressing Gfi1 WT or alanine substi-
tution mutants. Results of CFU assays are dis-
played as the percentage of CFU-G-, -M, and -GM
from three independent wells ± SD with total
number of colonies ± SD.
(D) Cytospin and 7/4 versus F4/80 flow-cytometric
analyses of 4 day G-CSF-stimulated liquid cul-
tures of Lin bone-marrow cells transduced with
MSCV empty vector (V), Gfi1 WT, and Gfi1
alanine-substitution mutants.Gfi1N382S Impairs Granulopoiesis by Restricting
SNAG-Dependent Cofactors
Mutation of the first proline in the Gfi1 SNAG transcriptional re-
pression domain (P2A) disrupts Gfi1-repression activity without
altering subcellular localization, protein accumulation, or DNA
binding (Grimes et al., 1996a). We reasoned that if the Gfi1N382S
mutant functions by sequestering corepressors necessary for
wild-type Gfi1 function, then a repressor-defective mutant
such as Gfi1P2A might reproduce Gfi1N382S effects by exclud-
ing wild-type Gfi1 from DNA binding sites. To test this hypothe-
sis, we introduced the P2A mutation in a murine Gfi1 cDNA and
tested its ability to regulate granulopoiesis. First, we transduced
Gfi1/ Lin cells with wild-type Gfi1- and Gfi1P2A-expressing
retroviruses and analyzed them for colony formation. Whereas
forced expression of Gfi1 in Gfi1/ Lin cells restored granulo-
poiesis (Figure 1F), colony formation of Gfi1P2A-expressing cells
was virtually indistinguishable from that of vector-transduced
cells (Figure 4A). Thus, it is unlikely that Gfi1P2A retains any abil-
ity to rescue Gfi1/ granulopoiesis. The ability of Gfi1 to modu-
late granulopoiesis appears to critically depend upon an intact
SNAG transcriptional-repressor domain.
Next, we assayed colony formation in wild-type Lin cells.
Similar to Gfi1N382S, Gfi1P2A-expressing cells gave rise to
mainly monocytic colonies (Figure 4B), and G-CSF-stimulated
liquid culture of Gfi1P2A-overexpressing cells resulted in a pre-
dominance of monocytic cells and a few immature neutrophilic
cells (Figure 4C). Moveover, Gfi1P2A-expressing G-CSF-stimu-
lated cultures showed a dramatic increase in mixed 7/4hi F4/80hi
cells (Figure 4D). In a manner strikingly similar to Gfi1N382S-ex-374 Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc.pressing cells, Gfi1P2A-overexpressing Lin bone-marrow cells
are blocked in granulopoiesis.
It is possible that both Gfi1N382S and Gfi1P2A act as domi-
nant-negative mutants that interfere with endogenous Gfi1-
directed granulopoiesis. We reasoned that if the dominant-nega-
tive activity of Gfi1P2A relies on DNA binding, whereas that of
Gfi1N382S depends upon an intact repression domain, then
a double mutant should lack dominant-negative activity. To test
this hypothesis, we constructed a Gfi1P2A+N382S mutant and
tested its ability to regulate granulopoiesis. In agreement with
our hypothesis, Gfi1P2A+N382S-expressing cells gave rise to
both monocytic and granulocytic colonies similarly to vector-
transduced cells (Figure 4B). Notably, the number of purely gran-
ulocytic colonies was lower in the Gfi1P2A+N382S-expressing
colonies than the empty-vector-transduced cells (p < 0.01), and
the number of Gfi1P2A+N382S-expressing 7/4hi F4/80hi cells
was variable. It is unlikely that the double mutant is completely
inactive; however, from both colony data and morphology, Gfi1-
P2A+N382S neutrophils were clearly formed (Figure 4C). Thus,
Gfi1P2A and Gfi1N382S act through a dominant-negative mech-
anism to block granulopoiesis, and granulocytic-differentiation
defects in Gfi1N382S-overexpressing cells can be rescued by
simultaneous mutation of the SNAG domain. We conclude that
Gfi1N382S most probably restricts granulopoiesis by interfering
with wild-type Gfi1 function.
Gfi1 Instructs Granulopoiesis
The data in sum do not delineate whether Gfi1 functions as an
instructive or a selective agent. Specifically, Gfi1 may function
Immunity
Murine Severe Congenital NeutropeniaFigure 4. N382S Functions as a SNAG-
Domain-Dependent Dominant Negative
(A) Methylcellulose colony formation of Gfi1/
Lin bone-marrow cells transduced with MSCV
empty vector (V) or MSCV encoding Gfi1P2A
(P2A). Results of CFU assays are displayed as
the percentage of CFU-G-, -M, and -GM from
three independent wells ± SD with total number
of colonies ± SD.
(B) Methylcellulose colony formation of wild-type
Lin bone-marrow cells transduced with MSCV
empty vector (V) or MSCV encoding Gfi1P2A or
Gfi1P2A+N382S; *p < 0.01.
(C and D) Cytospin (C) and 7/4 (D) versus F4/80
flow-cytometric analysis of 4 day G-CSF-stimu-
lated liquid cultures of Lin bone-marrow cells
transduced with MSCV empty vector (V) or
MSCV encoding Gfi1P2A or Gfi1P2A+N382S.
(E) Wild-type Lin bone-marrow cells transduced
with CMMP empty vector (V) or CMMP encoding
Gfi1 WT or Gfi1N382S were stimulated with
G-CSF and then analyzed by flow cytometry for
GFP and then for Annexin V versus 7AAD. The
average percentage of GFP+ early apoptotic
(Annexin V+ 7AAD) cells from three independent
experiments ± SD is shown.as a molecular switch to induce granulopoiesis, or Gfi1-overex-
pressing progenitors might only survive if they adopt a granulo-
cytic fate. To determine whether Gfi1 switches cellular fate of
progenitors or induces death of monocytic-determined progen-
itors, we monitored cell death daily in G-CSF-stimulated cultures
by Annexin V staining. In comparison to empty-vector-trans-
duced cells, Gfi1-expressing cultures demonstrated less apo-
ptosis, whereas Gfi1N382S-expressing cells showed a modest
increase in cell death in the third and fourth days of culture
(Figure 4E). Thus, cell death of monocytic lineage cells is unlikely
to explain Gfi1 effects on granulopoiesis. In agreement with this
concept, the forced coexpression of the antiapoptotic proteins
Bcl2 or Mcl1 did not reveal substantial differences in Gfi1 or
Gfi1N382S colony formation (Figure S2). We conclude that Gfi1
is instructive for granulocytic differentiation.
Gfi1N382S Blocks Granulopoiesis through Csf1
Because Gfi1-instructed granulopoiesis appears to require DNA
binding and transcriptional repression, we wished to delineate
relevant Gfi1 target gene(s). To this end, we analyzed RNA
from lineage-negative bone-marrow cells for transcripts whose
steady-state expression is increased in Gfi1/ versus wild-
type littermates. Recently, Laslo et al. demonstrated that Gfi1
may regulate the Egr1, Egr2, and Nab2 genes to resolve myeloid
lineage-fate decisions (Laslo et al., 2006). In addition, Zhuang
et al. have shown that in the 32D cell line, Gfi1N382S deregulates
CCAAT/enhancer binding protein, epsilon (Cebpe), expression
and induces apoptosis in response to G-CSF stimulation, subse-
quently blocking granulocyte formation (Zhuang et al., 2006).
Previous reports noted deregulated Csf1r expression in Gfi1/
myeloid cells (Hock et al., 2003) and suggested that this may
be due to direct interaction between Gfi1 and Pu.1 on the
Csf1r promoter (Dahl et al., 2007). Thus, we interrogated the
gene expression profiles of Egr1, Egr2, Nab2, Cebpe, and
Csf1r. Because deregulated expression of Csf1r would not befunctionally relevant to in vitro cultures without its ligand, we
also examined Csf1 expression. In comparison to wild-type lit-
termate Lin bone-marrow cells, we found that Egr1, Egr2,
Nab2 (Figure 5A), Csf1, and Csf1r (Figure 5C) transcripts were
indeed higher in Gfi1/ Lin cells. However, the expression of
Cebpe was only mildly elevated in Lin cells from Gfi1/ bone
marrow (Figure 5B). Thus, it is possible that Gfi1 regulation of
Egr1, Egr2, Nab2, Csf1, and Csf1r might explain the Gfi1N382S
phenotype.
Given the hypothesis that Gfi1N382S acts as a dominant neg-
ative, putative target genes responsible for the Gfi1N382S phe-
notype would be anticipated to be bound and repressed by
Gfi1 overexpression but activated by Gfi1N382S expression.
However, neither Egr1 nor Nab2 were repressed by Gfi1, and al-
though Egr2 transcripts were decreased in Gfi1-overexpressing
cells, they were also decreased in Gfi1N382S-expressing cells
(Figure 5D). Moreover, Cebpe was consistently upregulated by
expression of either Gfi1 or Gfi1N382S (Figure 5E). In contrast,
the accumulation of both Csf1 and Csf1r transcripts was de-
creased in bone-marrow cells overexpressing Gfi1 and elevated
in those expressing Gfi1N382S (Figure 5F). Thus, although Gfi1
may interact with Egr1, Egr2, Nab2, and Cebpe to regulate as-
pects of myelopoiesis, only the expression patterns of Csf1 and
Csf1r are in agreement with the hypothesized dominant-negative
function of Gfi1N382S. To determine whether Gfi1 binds to Csf1,
we utilized a computer program (Jegga et al., 2007) to reveal
a conserved Gfi1 binding site (50- GCCAGGGTGATTTCC-30) at
57 to 72 from the transcription start site of the Csf1 promoter.
EMSA revealed that in vitro-transcribed and -translated Gfi1
bound specifically to an oligonucleotide encoding the putative
Gfi1 binding site in theCsf1 promoter (Figure 5G). Chromatin-im-
munoprecipitation assays in U937 human myelomonocytic cells
revealed that endogenous Gfi1 was consistently and specifically
associated with the Csf1 promoter sequences, but not a b-actin
control (Figure 5H). Finally, quantitative real-time PCR analysesImmunity 28, 370–380, March 2008 ª2008 Elsevier Inc. 375
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poiesis by Deregulating Csf1 and Csf1r
(A–C) Taqman analyses of steady-state gene ex-
pression in RNA from wild-type (WT) or Gfi1/
(KO) littermate Lin bone-marrow cells (which
were not cultured ex vivo). Taqman values were
normalized to Gapdh, and the average fold ex-
pression from at least three independent samples
+ SD is shown.
(D–F) Taqman analyses of steady-state gene ex-
pression in Lin cytokine-expanded bone-marrow
cells transduced with MSCV empty vector (V) or
MSCV encoding Gfi1 or Gfi1N382S.
(G) EMSA analyses of in vitro-transcribed and
-translated Gfi1 binding to Csf1 promotor se-
quences.
(H) Fold enrichment of Csf1 promoter sequences
in chromatin-immunoprecipitation templates with
a Gfi1-specific monoclonal antibody versus con-
trol mouse IgG from quantitative PCR amplifica-
tion. The inset shows the ethidium-bromide-
stained products of the amplification reactions
for specific (Csf1) versus nonspecific (b-actin)
targets.
(I) Taqman analyses of human CD34+ bone-
marrow cells from three normal donors (average
normalized to one) versus a Gfi1N382S mutant
patient.
(J and K) Methylcellulose colony formation with
cytospin from colonies of Lin bone-marrow cells
transduced with MSCV empty vector (V) or MSCV
encoding Gfi1 or Gfi1N382S and then incubated
with a Csf1-inactivating monoclonal antibody or
an isotope-matched control IgG1k. Results of
CFU assays are displayed as the percentage of
CFU-G-, -M, and -GM from three independent
wells ± SD.
(L and M) Methylcellulose colony formation with
cytospin from colonies as in (J) and (K) with
Csf1/(op/op) bone-marrow cells.of RNA from CD34+ cells obtained from normal or Gfi1N382S pa-
tients revealed a dramatic CSF1-transcript induction, which
dwarfed a modest induction of CSF1R (Figure 5I). Thus, Gfi1 di-
rectly targets the Csf1 promoter for transcriptional repression in
that Csf1 was repressed by Gfi1 overexpression, deregulated in
Gfi1/ and Gfi1N382S-expressing human and murine cells,
and directly bound by Gfi1 in EMSA and ChIP.
Next, we directly tested the relevance ofCsf1 andCsf1r dereg-
ulation to the Gfi1N382S phenotype. We transduced Lin bone-
marrow cells with retroviral vectors expressing Gfi1 or Gfi1N382S
and performed colony assays with either a monoclonal antibody
that binds and inactivates Csf1 or an IgG1k isotype-matched
control. The Csf1-inactivating antibody dramatically increased
the number of Gfi1N382S mixed colonies at the expense of solely
monocytic colonies (Figure 5K). Importantly, the morphology of
many of the cells within these mixed colonies was clearly that
of neutrophils (Figure 5J). Interestingly, the gene-expression
profile of Egr1, Egr2, and Nab2 was similar, whereas the expres-
sion ofMPO andNE were modestly increased, in Csf1-antibody-
treated Gfi1N382S-expressing- versus vector-control-trans-376 Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc.duced cells (data not shown). Likewise, genetic ablation of Csf1
blocked the effects of Gfi1N382S expression in that colony for-
mation was not different from wild-type littermate bone marrow
(Figure 5L) and that neutrophil morphology was visible (Fig-
ure 5M). As expected from published reports (Wiktor-Jedrzejczak
et al., 1990; Yoshida et al., 1990), abnormal vesicles are seen in
Csf1/ cells independent of Gfi1N382S expression (Figure 5M).
With the same conditions for Lin cell culture, the addition of re-
combinant murine Csf1 induced the dose-dependent conversion
of colonies to a monocytic phenotype (Figure S3). Thus, restrict-
ing the biological activity of the Csf1 generated by Gfi1N382S-
expressing cells permitted these cells to form granulocytes.
DISCUSSION
Patients with severe congenital neutropenia (SCN) display muta-
tions in ELA2,GFI1,WAS, andHAX1 (Devriendt et al., 2001; Klein
et al., 2007; Person et al., 2003), but mutations in ELA2 predom-
inate (Horwitz et al., 2007). Modeling mutant Ela2 in primary
murine cells has failed to mimic SCN (Grenda et al., 2002), and
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contrast, our data clearly show that expression of murine
Gfi1N382S in otherwise normal murine Lin stem and progenitor
cells blocks granulopoiesis in a manner strikingly similar to
Gfi1N382S patient samples processed in a comparable manner.
Although Gfi1/ mice and Gfi1N382S patients have a similar
block to granulopoiesis (Hock et al., 2003; Karsunky et al.,
2002b; Person et al., 2003), our data reveal selective deregula-
tion of putative Gfi1 targets by Gfi1N382S. Thus, deletion of
murine Gfi1 engenders severe transcriptional changes that are
apparently not relevant to Gfi1N382S-mediated human disease.
Similarly, expression of Gfi1N382S in the 32D cell line results in
profound G-CSF-induced cell death instead of differentiation
(Zhuang et al., 2006), which did not occur in primary Lin cells.
Neither the 32D cell line nor Gfi1/ mice represent a self-suffi-
cient model of Gfi1 mutant SCN.
Of the putative Gfi1 target genes we examined, only Csf1 and
Csf1r were deregulated in Gfi1/ bone-marrow cells, repressed
by Gfi1, and derepressed by Gfi1N382S. It is currently unclear
why Gfi1N382S regulates Csf1 differently than Cebpe, Egr1,
Egr2, and Nab2. However, we have shown that Gfi1 binds to
the Csf1 promoter in living U937 cells. In SCN patients and murine
Lin cells, Gfi1N382S may require an intact SNAG repressor
domain to compete for corepressors utilized by Csf1-promoter-
bound wild-type Gfi1. Regulation of Csf1 and its receptor are
obviously critical for Gfi1N382S action because antibody absorp-
tion of Csf1 in culture or genetic ablation of Csf1 released the
Gfi1N382S block to granulopoiesis. Although inactivation of
Csf1 did not perfectly restore myelopoiesis, the granulocytes
formed from Gfi1N382S-expressing cells without Csf1 support
the hypothesized dominant-negative activity of Gfi1N382S.
Clearly, Gfi1 regulates multiple targets and the expression of
Gfi1N382S may be used to selectively identify target genes that
are critical to granulopoiesis and to the pathogenesis of SCN.
Previously, mutations found in humans with SCN, introduced
into the corresponding murine cDNA, and expressed in primary
murine cells failed to block the production of mature murine gran-
ulocytes. Given our results, it is perhaps not surprising that
Gfi1N382S, which engenders the most severe mutant phenotype
we observed, was identified in the patient population. Other zinc-
finger amino acid substitutions, although not as potent as
Gfi1N382S, are clearly capable of interfering with granulopoiesis.
Although neutrophil elastase mutants do not successfully model
SCN in mice, and thus highlight differences in myelopoiesis be-
tween rodents and humans, expression of GFI1N382S (and other
Gfi1 mutants) in primary Lin bone-marrow cells illustrates a cen-
tral transcriptional program that controls neutrophil development
and that is relevant to the pathogenesis of SCN.
Although Gfi1 may have an array of transcriptional targets in
different cell types, the subset of these genes relevant to
Gfi1N382S-induced SCN may be restricted to monopoietic
genes in progenitors. That Gfi1 influences granulopoiesis by re-
stricting the expression of monopoietic genes in neutrophils is
currently a matter of debate. Several studies (Dahl et al., 2007;
Hock et al., 2003; Laslo et al., 2006) have suggested that mono-
cytic genes are repressed by Gfi1, but recent work on Gfi1-pro-
tein degradation suggested that Gfi1 only accumulates in mono-
cytic cells. Gfi1 may thus function to repress granulocytic genes
in monocytes (Marteijn et al., 2006). Although this possibility hasnot been excluded, neutrophils from Gfi1+/ animals have de-
regulated transcription of secondary granule-protein-encoding
genes (Khanna-Gupta et al., 2007), suggesting that there is suf-
ficient Gfi1 protein in neutrophils to regulate granulocytic genes.
Our own data show that Gfi1 instructs granulopoiesis and that
Gfi1N382S critically deregulates the expression of Csf1 to
induce monopoiesis.
Gfi1 is rate limiting for granulopoiesis. Our data demonstrate
that Lin bone-marrow cells from Gfi1+/ mice generated sub-
stantially fewer granulocytic colonies than Gfi1+/+ littermates.
Thus, physiological manipulation of Gfi1 dosage affects lineage
fate. In addition, retroviral-vector-mediated expression of Gfi1
rescued a normal ratio of granulopoietic and monopoietic colo-
nies from Gfi1/ Lin bone-marrow cells, whereas it ablated
monocytic-colony formation in Gfi1+/+ Lin bone-marrow cells.
The amount of Gfi1 achieved in our experiments (and not deregu-
lated expression) appears to influence lineage choice.
Both DNA-binding and transcription-repression functions ap-
pear critical for Gfi1 instruction of granulopoiesis. Gfi1 can appar-
ently function as a molecular sink for the Pias3 SUMO E3 ubiquitin
ligase and the U2AF26 splicing factor (Heyd et al., 2006; Rodel
et al., 2000). Notably, these functions do not require DNA binding
or an intact SNAG domain. If the biologically available amount of
Pias3 or U2AF26 were the critical regulator of lineage fate, then
either Gfi1N382S or Gfi1P2A should have bound these proteins
and rescued Gfi1/ granulopoiesis, but they did not. In agree-
ment with these data, Fiolka recently showed that mice with ho-
mozygous Gfi1P2A knockin alleles have Gfi1/ phenotypes
(Fiolka et al., 2006). On the other hand, we note that although
granulopoiesis was restored in Gfi1P2A+N382S-expressing
cells, the number of granulocytic colonies is not completely nor-
mal. Because neither Gfi1P2A nor Gfi1N382S mutations would
be expected to disrupt Pias3 or U2AF26 interactions, the residual
activity of the Gfi1P2A+N382S mutant might be explained by Gfi1
binding to these proteins. In contrast, Gfi1 antagonism of Pu.1 re-
quired the SNAG domain, but not DNA binding (Dahl et al., 2007).
We observed a lack of granulopoiesis in both Gfi1N382S- and
Gfi1P2A-expressingGfi1/ Lin bone-marrow cells. If the major
defect in Gfi1/ Lin cells were overactive Pu.1, then the
Gfi1N382S but not the Gfi1P2A mutant should have been capa-
ble of some rescue, but neither mutant rescued Gfi1/ granulo-
poiesis. These data emphasize the requirement for both Gfi1
DNA binding and transcription-repression functions to instruct
granulopoiesis.
Our data support the hypothesis that a greater amount of Gfi1
resolves the fate of mixed-lineage cells (Laslo et al., 2006). It is al-
ternatively possible that Gfi1 functions through cell-cycle or cell-
death pathways to limit monocytic-colony formation. However,
cell-cycle analysis of Gfi1- or Gfi1N382S-expressing cytokine-
stimulated Lin bone-marrow cells did not reveal substantial dif-
ferences (data not shown). Moreover, Gfi1 was antiapoptotic in
cytokine-stimulated bone-marrow progenitors; as already estab-
lished in T cells (Grimes et al., 1996b; Karsunky et al., 2002a).
Although Gfi1 was recently shown to block Pu.1-induced macro-
phage development in a cell line (Dahl et al., 2007), our work dem-
onstrates that forced expression of Gfi1 instructs granulopoiesis
in a DNA-binding and SNAG-domain-dependent manner not
explained by Pu.1 interactions. Instead, primary wild-type Lin
cells yielded almost exclusively granulocytic colonies withImmunity 28, 370–380, March 2008 ª2008 Elsevier Inc. 377
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were stimulated with G-CSF in liquid culture, Gfi1-expressing
cells had a uniform neutrophilic surface phenotype (7/4+F4/80)
and were morphologically more mature than vector-transduced
cells. In addition, a striking reduction of not only monocytic
(7/4F4/80+) but also mixed lineage (7/4+F4/80+) phenotype cells
occurred. In sum, Gfi1 is a rate-limiting granulocytic switch that
represses critical monopoietic target genes (such as Csf1 and
Csf1r) to resolve cell-fate decisions in progenitor cells.
EXPERIMENTAL PROCEDURES
Plasmids and Virus Production
For the construction of Gfi1 mutants, the Bci6-HincII DNA fragment of the mu-
rine Gfi1 cDNA (gift from T. Mo¨ro¨y) was first cloned into pCR-BluntII-TOPO vec-
tor (Invitrogen); then, the SNAG domain P2A and zinc finger N382S mutations
were introduced with Quickchange II site-directed mutagenesis kit (Strata-
gene) and confirmed by sequencing. The BamHI-NotI DNA fragments were
cloned into pcDNA3.1(+) for IVT. For virus production, the EcoRI DNA frag-
ments were cloned into either the MSCV-puro (Hawley, 1994) or MMP-ires-
GFP (Klein et al., 2000) retroviral vectors. Phoenix-Eco packaging cells were
transfected with the viral vectors for viral supernatant generation.
Transient Transcription Assay and Immunoblotting
A chloramphenicol acetyltransferase (CAT) assay was performed as described
elsewhere (Zweidler-Mckay et al., 1996). In brief, 400 ng of either B30TKCAT or
TKCAT were cotransfected with 10 ng of MSCV vectors encoding Gfi1 or
Gfi1N382S into HEK293 cells with Lipofectamine2000 (Invitrogen). Thirty-six
hours later, cells were lysed and CAT activity was determined by the scintilla-
tion method, and proteins were detected through immunoblot analyses with
a rabbit polyclonal antisera directed against a peptide encoding Gfi1 amino
acids 12–26.
Bone-Marrow Lin Cells Isolation and Retroviral Infection
Mice were bred and housed by CCHMC Veterinary Services, and mouse ma-
nipulations were reviewed and approved by the Children’s Hospital Research
Foundation IACUC. Bone-marrow Lin cells were isolated from both 6- to
8-week-old C57Bl/6 WT mice and Gfi1 mutant littermates or Csf1/(op/op)-de-
ficient mice (Yoshida et al., 1990). Bone marrow was flushed from both femurs
and tibias with PBS containing 0.5% FBS, then labeled with the mouse Line-
age Cell Depletion kit (Miltenyi Biotec); this was followed by separation on
AutoMacs magnetic sorter (Miltenyi Biotec). Cells were maintained in serum-
free StemSpan medium (StemCell Technologies) supplemented with IL-3
(10 ng/ml), IL-6 (20 ng/ml), SCF (25 ng/ml), and TPO (25 ng/ml) and various
concentrations of Csf1 (all from PeproTech). After 48 hr of cytokine expansion,
the cells were subjected to retroviral transduction. In brief, six-well non-tissue-
culture-treated plates were coated with Retronectin (TaKaRa) according to the
manufacturer’s protocol and preloaded with viral particles. A total of 2 3 106
cells were plated per well and spinfected at 1000 g for 1.5 hr.
Methylcellulose Assay, Liquid Cultures, and Flow Cytometry
One day after MSCV-puro retroviral vector transduction, 63 103 cells/ml were
plated in MethoCult GF M3534 containing IL-3, IL-6, and SCF (StemCell Tech-
nologies) with 2.5 mg/ml of puromycin (Sigma). Alternatively, 36 hr after CMMP
retroviral-vector transduction, GFP+ cells were sorted and plated in Metho-
Cult. Hematopoietic colonies containing more then 50 cells were scored at
day 7 or 8 and differentiated on the basis of their morphology. For experiments
involving neutralization of Csf1 bioactivity, Lin cells were transduced with
retroviral vectors and plated in triplicate in Methocult in the presence of
350 ng/mL monoclonal antibody that neutralizes Csf1 (clone 5A1, BD Biosci-
ences) or a rat IgG1, k isotype control (BD Biosciences). Results are displayed
as the percentage of CFU-G, -M, and -GM from three independent wells ± SD
with total number of colonies ± SD (‘‘col. no:’’). Assays were repeated at least
three times with similar results. For liquid cultures, 1 day after retroviral-vector
transduction, the cells were plated in Iscove’s DMEM with 10% FBS and
2.5 mg/ml of puromycin and stimulated for 4 days with 5 ng/ml of murine378 Immunity 28, 370–380, March 2008 ª2008 Elsevier Inc.G-CSF (Pepro Tech). The cells were then subjected to either cytospin (and then
Giemsa or Hematoxylin-Eosin staining) or flow cytometry. In brief, cells were
stained with antibodies to 7/4 (clone 7/4, Serotec) and F4/80 (clone CI:A3-1,
Serotec), or Annexin-V-APC and 7-AAD (BD-PharMingen), then analyzed on
an LSRII flow cytometer (BD-Biosciences) with FloJo software (TreeStar).
Representative flow plots are shown with statistical analyses from at least
three independent experiments.
RNA Isolation and Real-Time PCR
We isolated total RNA with the RNeasy Mini Kit (QIAGEN) and digested it with
DNase I (Ambion) to remove DNA contamination. A total of 1 mg of RNA was
used for reverse transcription with random hexamers in the TaqMan Reverse
Transcription System according to the manufacturer’s instructions (Applied
Biosystems) and then analyzed with TaqMan probes targeting Egr1, Egr2,
Nab2, Cebpe, Csf1, Csf1r, and b-actin transcripts (Applied Biosystems). The
expression of the glyceraldehyde-3-phosphate dehydrogenase (Gapdh) gene
was used for normalizing samples. The average fold expression from at least
three independent samples ± SD is shown.
Molecular Modeling
An alignment of the zinc fingers of 1MEY to zinc fingers 3, 4, and 5 of Gfi1 was
carried out with ClustalW (Eddy, 1995). On the basis of this alignment, a homol-
ogy-modeled structure for Gfi1 zinc fingers 3, 4, and 5 was generated by Mod-
eler V8.0, employing the crystal structure of 1MEY (Kim and Berg, 1996) as the
template. Zinc ions were included and crystal-structure-derived distance
constraints were used for maintaining the zinc finger topology. The resulting
structure was used as a starting point for molecular dynamics simulations
with AMBER8.0 (Case et al., 2005). Specifically, we used Xleap to generate
the water-solvated system comprising a homology model of Gfi1 with TIP3P
solvent molecules and ions added for neutrality. Standard equilibrium and pro-
duction-run protocols were used (Trent, 2001). Molecular-dynamics simula-
tions were performed with the parm99 force field with AMBER 8.0 and the
mpi Sander module in the isothermal isobaric ensemble (p = 1 atmosphere);
isotropic pressure scaling (ntp = 1), periodic boundary conditions with PME,
1.5 fs time step, and frozen hydrogen atoms were calculated with SHAKE.
The models were solvated in 10 A˚ box of water with xleap. Counter ions were
added randomly for overall charge neutrality. The system was equilibrated
for 125 ps, with restraints on the position of the zinc being kept constant with
weights of 100 Kcal. Unrestrained production run of 2 ns was carried out. Anal-
ysis was carried out of the snapshots as well as on the averaged structure gen-
erated from the last 25 ps of the production run. Calculations were performed
on 16 R12000 processor Silicon Graphics Origin 2000 server.
Electrophoretic Mobility-Shift Assay
The pcDNA3.1(+) vector templates were in vitro transcribed-translated with
the TnT Coupled Reticulocyte Lysate System and T7 polymerase (Promega)
according to the manufacturer’s protocol. For confirming protein synthesis,
the reaction was also performed in the presence of S35 Cysteine and Methio-
nine, resolved on SDS-PAGE, dried, and exposed to BiomaxMR film (Kodak)
with a Biomax Transcreen-LE intensifying screen (Kodak). To perform
EMSA, we incubated 0.5 ml of in vitro transcribed-translated proteins with
50,000 cpm of P32 end-labeled R21 probe 50-GGACCGGGGTGCAGTGATTT
GGTGTGGCGATC-30, R21 mutant 50-GGACCGGGGTGCAGTGACCTGGTG
TGGCGATC-30, or Csf1 probe 50-GGAGCCAGGGTGATTTCCCATAAACCA-
30 in a reaction mixture containing 10 mM HEPES (pH 7.6), 10% glycerol,
10% NP-40, 50 mM NaCl, 0.5 mM DTT, 50 ng/ml poly (dI-dC) (Sigma), and
2.5mg/ml nonfat milk for 30 min at RT. Complexes were resolved by electropho-
resis on 6% acrylamide gels in 0.53 TBE buffer at 4C. The gels were dried and
exposed to BioMax MS films (Kodak) with a TranScreen-HE intensifying
screens (Kodak) at 70.
Statistical Analysis
All experiments were repeated at least three times and analyzed with ANOVA
test and the StatView computer program.
Chromatin-Immunoprecipitation Analysis
The chromatin immunoprecipitation (ChIP) assay was essentially performed as
described previously (Doan et al., 2004). U937 cells (23 108) were fixed in 1%
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were resuspended in cell-lysis buffer (50 mM Tris-HCl [pH 8.1], 10 mM EDTA
[pH 8.0], 10% glycerol, 1% SDS, and 13 complete protease inhibitor) and in-
cubated on ice for 10 min. Cells were then sonicated with a Sonicator 3000 cup
horn (Misonix) on ice for generation of soluble chromatin complex with DNA
fragments of <1 kb length. Approximately 1.5 ml of soluble chromatin was
used per reaction for immunoprecipitation with antibody to Gfi1 (clone
2.5D.17) and control mouse IgG (NA931V, GE Health care). Quantitative
PCR was performed with SYBR Green (Applied Biosystems) on an iCycler (Bi-
oRad) with Csf1 (50-GGGCCTCTGGGGTGTAGTAT-30 and 50-CCGAGGCAA
ACTTTCACTTT-30; product size 189 bp) or b-actin (50-AGCGCGGCTACAGCT
TCA-30 and 50-CGTAGCACAGCTTCTCCTTAATGTC-30; product size 120 bp)
primer pairs. b-actin was used as a control for nonspecific enrichment.
SUPPLEMENTAL DATA
Three figures are available at http://www.immunity.com/cgi/content/full/28/3/
370/DC1/.
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